DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Pollack Jr CV, Reilly PA, van Ryn J. et al.
Idarucizumab for Dabigatran Reversal – Full Cohort Analysis.
N Engl J Med 2017;
377: 431-441
We do not assume any responsibility for the contents of the web pages of other providers.